Chinese tumor treatment system used for first non-invasive surgery in Vietnam　

(ECNS) -- China's original “HIFU” (High-intensity focused ultrasound) tumor treatment system has been used to successfully perform the first nonsurgical treatment for uterine fibroids in Vietnam, according to the State Key Laboratory of Ultrasound in Medicine and Engineering (SKLUME) on Monday.

In September, Professor Nguyen Viet Tien, president of Thien An Obstetrics Hospital in Hanoi introduced China’s original “HIFU” tumor treatment system to Vietnam.

Led by Dr. He Min of Chongqing Haifu Hospital in southwest China, Thien An staff completed the country's first non-invasive uterine fibroid treatment using the HIFU system.

HIFU is a non-invasive treatment that directs ultrasound waves onto target tissue inside the body. It uses ultrasound to generate temperatures from 65 to 100 degrees Celsius, damaging target tissue. The procedure is painless, bloodless, and radiation-free without surgery or bleeding. It is used to treat various tumors, including uterine fibroids, breast fibroadenomas, breast cancer, liver tumors, bone tumors, and soft tissue tumors.　

The “HIFU” tumor treatment system, developed by Professor Wang Zhibiao of the SKLUME, has been exported to 32 countries and regions. It has received market access in 47 countries and established over 400 minimally invasive treatment centers worldwide.

The Vietnam Ministry of Health and Health Department of Hanoi plan to launch the first pilot at Thien An, aiming to treat 20 tumor patients with non-invasive procedures.

This technology can treat tumors of up to 20 centimeres (in diameter?), allowing Vietnamese patients to receive treatment locally, saving time and money, said Professor Nguyen, highlighting that it is a major step forward not only for THIEN AN but also for the development of healthcare in Vietnam.